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Objective:“Michael’s game” (MG) is a card game targeting the ability to generate
alternative hypotheses to explain a given experience. The main objective was to evaluate
the effect of MG on delusional conviction as measured by the primary study outcome: the
change in scores on the conviction subscale of the Peters delusions inventory (PDI-21).
Other variables of interest were the change in scores on the distress and preoccupation
subscales of the PDI-21, the brief psychiatric rating scale, the Beck cognitive insight
scale, and belief flexibility assessed with the Maudsley assessment of delusions schedule
(MADS).
Methods: We performed a parallel, assessor-blinded, randomized controlled superiority
trial comparing treatment as usual plus participation in MG with treatment as usual plus
being on a waiting list (TAU) in a sample of adult outpatients with psychotic disorders and
persistent positive psychotic symptoms at inclusion.
Results: The 172 participants were randomized, with 86 included in each study arm.
Assessments were performed at inclusion (T1: baseline), at 3months (T2: post-treatment),
and at 6months after the second assessment (T3: follow-up). At T2, a positive treatment
effect was observed on the primary outcome, the PDI-21 conviction subscale (p=0.005).
At T3, a sustained effect was observed for the conviction subscale (p=0.002). Further
effects were also observed at T3 on the PDI-21 distress (p=0.002) and preoccupation
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subscales (p=0.001), as well as on one of the MADS measures of belief flexibility
(“anything against the belief”) (p=0.001).
Conclusion: The study demonstrated some significant beneficial effect of MG.
Keywords: psychotic disorders, schizophrenia, cognitive therapy, game, hypothetical reasoning, random-
ized controlled study, psychotherapy
Introduction
A considerable proportion of patients with psychotic disorders do
not respond fully to antipsychotic agents (1). As an adjunct treat-
ment, however, cognitive behavioral therapy (CBT) has, to some
extent, a favorable effect on psychotic symptoms (2–7), awareness
of illness, distress, preoccupation, conviction, and behavioral con-
sequences of delusional beliefs (8–11). A core component of CBT
is based onhypothetical reasoning, which consists of the search for
alternative explanations for a given experience (12). Delusions are
associated with low belief flexibility, with most patients unable to
spontaneously find alternative explanations for their beliefs (13).
Promoting an alternative hypothesis may reduce their degree of
conviction, preoccupation, and distress associated with delusions
(14, 15).
Despite an increasing need for trained professionals who are
able to deliver CBT for psychotic symptoms in naturalistic set-
tings, studies have emphasized that training opportunities are
lacking and that the numbers of qualified therapists are poor (16–
18). Moreover, most studies in the field have been performed
in CBT specialized settings with highly selected patients (19). A
number of preliminary studies have shown, however, that new
tools that integrate CBT techniques in game format (20, 21) and
some forms of computer-assisted therapy (22) represent promis-
ing treatment for patients with psychotic disorders.
“Michael’s game” (MG) (Table 1) is a hypothetical reasoning
training module that promotes the dissemination of CBT (specif-
ically, reasoning training) in natural clinical settings. It is based
on CBT of psychotic symptoms (5, 23, 24), as described elsewhere
(20, 21). The aim of the game is to train people to find alternative
hypotheses for a given situation.
Two preliminary studies (20, 21) support the possible impact of
the game on psychotic symptoms.
Those earlier studies had, however, a number of limitations
such as lack of control group, lack of blind assessment, the non-
controlled character of the pharmacological treatments, as well as
the lack of follow-up measures.
Furthermore, the consistency of the intervention was not con-
trolled by audio recording of the sessions. The study at hand
aimed to overcome the weakness of the previous works with more
rigorous methods such as a randomized controlled design, blind
assessments, sessions recording, and a follow-up assessment.
In the present randomized controlled trial, we hypothesized a
more important impact of “treatment as usual+Michael’s game”
(MG) than of “treatment as usual+waiting list” (TAU) on a
measure of psychotic symptoms related to conviction (primary
outcome) and possibly on measures of distress, preoccupation,
symptom intensity, belief flexibility, cognitive insight, awareness
of illness, and actions on beliefs (secondary outcomes).
TABLE 1 | “Michael’s game.”
Examples of objectives on the cards
Describe a situation before interpretation
Devise the interpretation of a situation as a hypothesis
Search for different interpretations of the same situation
Identify the cognitive and behavioral consequences of the different hypotheses
Search for a link between the interpretation given for a situation and a personal
real-life experience
Put the hypotheses in hierarchical order in terms of their probability
Search for arguments for or against a hypothesis
Think of a way of testing a given hypothesis in reality
Examples of cards
A non-psychotic and non-emotional situation card
Michael sets two bags of different sizes on each side of a scale
The big bag has the same weight as the small bag
Michael is surprised since the two bags are supposed to be filled with cotton
He thinks that the small bag contains a stone
A psychotic card
Michael is watching his favorite show on television
When the show host appears, Michael is so pleased that he bursts out laughing
The show host and another participant in the show start laughing at the same time
Michael tells himself: “My joy is contagious”
The game was conceived by two of the authors, Yasser Khazaal and Jerome Favrod. It
has been translated into English, French, Spanish, German, and Italian. The game includes
non-psychotic, non-emotional cards (1–11); emotional, non-psychotic cards (12–32); and
psychotic cards (33 to the end).
The aim of the trial is to assess the short-term effect (post-
intervention) of MG in comparison to TAU on the primary
outcome and on further secondary outcomes. The sustained or
long-term effect of the intervention in comparison to TAU was
also evaluated 6months after the post-intervention assessment of
the primary and secondary outcomes.
Materials and Methods
Participants were outpatients recruited in psychiatric rehabilita-
tion units and outpatient clinics in Switzerland, France, Monaco,
and Italy. Potential participants were identified through system-
atic screening of medical records. Written informed consent was
obtained from all participants. Institutional review boards and the
ethical committees in Switzerland, France, and Italy approved the
study protocol. The protocol was also made available to all study
investigators andwas registered (International Standard Random-
ized Controlled Trial Number Register: ISRCTN37178153)1. The
study was carried out from October 2008 to September 2011. The
study’s duration was longer than initially expected because of a
delay in the recruitment process. The study had, however, slightly
higher recruitment of participants than first planned (172 rather
than 166) and a higher retention rate than originally expected (124
1http://www.controlled-trials.com/ISRCTN37178153/
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patients assessed at the end point rather than the 94 projected).
There were no other deviations from the original study protocol.
Randomization
Eligible patients were randomized to either TAU or to MG after
providing informed consent. The randomization schemewas gen-
erated by using the website randomisation.com2 and kept inde-
pendently by a statistician. The allocation ratio used was one
to one. A permuted-block randomization procedure was used
with fixed block sizes of four patients, ensuring that the number
of subjects in the different groups closely balanced at all times.
The study investigators, who were in charge of enrollment, were
blinded to the randomization sequence in order to prevent them
from predicting patient allocation, thus reducing selection bias.
There was no randomization by center.
Assessment Procedures
Patients were assessed at baseline (T1); at 3months, after the end
of theMG sessions (T2); and 6months after the second assessment
(T3). Psychologists or psychiatrists made the assessments inde-
pendently from the therapists, and the game leaders and were not
informed of the treatment received by the participants (blind eval-
uation). The patients were given 40 Swiss francs (approximately 35
Euros or 40 US Dollars) as compensation after each evaluation.
Measures
 Mini-international neuropsychiatric interview (MINI) (25)
for psychiatric diagnosis according to the DSM-IV.
 Peters delusions inventory (PDI-21) (26, 27). Multidimen-
sionality of delusions is approached in the PDI-21 by mea-
suring distress, preoccupation, and conviction related to
each of 21 stated beliefs on a 5-point Likert scale. Patients
with psychotic disorders differ from controls by having
higher ratings on distress, preoccupation, and conviction
scales (26). The scales were proposed as a possible measure
of change during CBT (26). Results of preliminary studies
(20, 21) showed a treatment time effect on the scores of
the PDI-21.
 Brief psychiatry rating scale (BPRS) (28). The following
scores were considered: affect, positive symptoms, negative
symptoms, resistance, activation (29), and total score.
 Beck cognitive insight scale (BCIS) (30, 31). The BCIS is
composed of two subscales: self-reflectiveness related to the
ability to consider alternate explanations and openness to
feedback, and self-certainty related to the degree of certainty
and confidence related to beliefs. A BCIS composite index
is obtained by subtracting the self-certainty from the self-
reflectiveness score. It was hypothesized (32) that low self-
reflectiveness and high self-certainty (low composite index)
may constitute a reasoning style that would maintain delu-
sional beliefs.
 Global assessment of functioning (GAF) scale (DSM-IV).
 Social and occupational functioning assessment scale
(SOFAS).
 Maudsley assessment of delusions schedule (MADS) (33).
MADS is a standardized interview designed to evaluate the
2http://www.randomization.com
phenomena related to the principal abnormal belief of a
patient. In practice, the MADS improves the assessment of
the possible impact of the game on specific and individu-
alized aspects of the main delusional idea of each included
patient and on measures of belief flexibility specifically
linked with the main delusional belief. The followingMADS
assessments were included in the study:
 Belief flexibility. As suggested elsewhere (15), the partici-
pants were asked whether or not it was possible that they
may bemistaken about their main belief (possibility of being
mistaken). They were also presented with a hypothetical
scenario, which, if true, would contradict the delusion, and
asked how this would change their belief (change convic-
tion). The participants were also asked whether or not any-
thing has happened that goes against the belief and “What
would have to happen to make you think that you might be
wrong about this belief?” This assessment could be consid-
ered as a form of “ability to plan a behavioral experiment.”
 Awareness of illness.
Primary Outcome
The primary outcome was the change after treatment in the
conviction score of the PDI-21.
Secondary Outcomes
The 16 secondary outcomes included the change in scores on the
other two subscales of the PDI-21 (distress and preoccupation),
the five subscales of the BPRS, the two subscales of the BCIS, the
GAF, the SOFAS, and the five items of the MADS.
Sample Size and Power
An a priori sample sizewas estimated froma pilot study (21), using
the conviction subscale of the PDI-21 in the calculation. By using
the Diggle formula for the sample size calculation in longitudinal
data, we found that a sample size of at least 47 persons per group
was needed at each study evaluation (error rate of 0.05; statistical
power of 0.8).
Inclusion Criteria
 Psychotic disorder according to the DSM-IV (diagnostic
based on chart review and MINI)
 Outpatient setting
 18–65 years old
 Persistent positive psychotic symptoms at inclusion: BPRS
score of 3 on at least two items of the positive symptoms
BPRS subscale
Exclusion Criteria
 Organic brain disease
 Mental retardation
 BPRS conceptual disorganization score>5
 Prior participation in MG
 Cognitive therapy of psychotic symptoms at inclusion
Interventions
Michael’s Game
Michael’s game is a collaborative group game consisting of 80 cards
(Table 1). Each card corresponds to a situation and to objectives
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that target the ability to reason with hypotheses (see Table 1 for
an example of a card). Training group leaders (two per session)
direct the game during weekly sessions lasting for about 1 h.
Because MG is an 80-card game, the mean number of sessions
needed to end the game is not a priori fixed. The mean number of
sessions needed to end the game was 12.1 (SD= 3.41). The mean
participation rate of the participants (number of sessions com-
pleted by a participant 100/total number of sessions needed to
complete the program in the same group) was 91.2% (SD= 14.1).
These figures are similar to those described in the preliminary
reports related to the game (20). Failure to attend more than three
sessions was considered to be MG treatment discontinuation.
Participants (in groups of four to eight patients) are led through
specific questions to find multiple answers (hypotheses) to the
questions and conclusions that Michael draws from the situations
that he is confronted with. In other words, participants have to
help Michael to find alternatives to the conclusions that he draws
from situations described on each card. MG was conceived as a
collaborative group card game in order to allowpatients to become
partners of a fictive character (Michael) and together to interact
with cards containing impersonal information that may reflect
their own concerns. Participants play together on objectives such
as the following: describe the situation reported on a given card,
identify Michael’s hypothesis, search for different hypotheses that
may explain the same situation, report the possible cognitive and
behavioral consequences of the different hypotheses, give argu-
ments for or against a given hypothesis, and imagine how to test a
given hypothesis in reality. Game directors were psychiatric care
workers (nurses: 14, psychologists: 12, psychiatrists: 6) who were
specifically trained to deliver MG according to the training model
described below.
Treatment as Usual Plus Waiting List (TAU; Control
Condition)
Treatment as usual comprises case management, psychosocial
interventions, antipsychotic medication, and outpatient and com-
munity follow-up. The patients in the TAU condition had to wait
until the end of follow-up before participating in a MG.
The collaborative centers had access to similar pharmaco-
logical treatment, psychosocial structures, and level of med-
ical training. Medication was monitored during the study.
Chlorpromazine equivalences were calculated for antipsychotic
medications according to Woods (34). Participants from both
groups received treatment as usual throughout the entire study
period.
Assessed for eligibility (n= 260)
Excluded  (n= 88)
• Not meeting inclusion criteria (n=58)
• Declined to participate (n=30)
Lost to follow-up (n= 8)
Reasons for dropout:
• consent withdrawn (n=1) 
• unknown reasons (n=7) 
Analysed (n=86)
Lost to follow-up (n=23)
61% of whom discontinued the allocated treatment
(n=14)
Reasons for dropout:
• worsening of psychosis (n= 7) 
• travel (n=1)
• unknown reasons (n=15) 
Analysed (n=86)
Lost to follow-up (n=7)
Reasons for dropout:
• unknown reasons (n=7) 
Analysed (n=86)
Randomised (n=172)
*T2: 3 months aer the end of the Michael’s Game sessions 
**T3: 6 months aer T2
***Dropped only from MG (n=6); dropped from MG+TAU (n=4)
Allocated to Michel’s Game (MG) (n=86)
• Started allocated intervention (n=86)
Allocated to treatment as usual (TAU)  (n=86)
• Started allocated intervention (n=86)
Lost to follow-up (n=10)
100% of whom discontinued the allocated treatment****
(n=10)
Reasons for dropout:
• worsening of psychosis (n= 5) 
• problems with physical health (n=1)
• unknown reasons (n=4) 
Analysed (n=86)
Follow-up and 
Analysis at T3**
Follow-up and 
Analysis at T2*
Allocation
FIGURE 1 | CONSORT flow diagram.
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TABLE 2 | Baseline sociodemographic and clinical characteristics of the
participants in the Michael’s game (MG) and the treatment as usual (TAU)
groups.
Baseline variables TAU MG p-Value
(n= 86) (n= 86)
Mean (SD)
or %
Mean (SD)
or %
Age 37:1 (10:8) 37:0 (10:1) 0:9
Gender: male 67:4 57:0 0:2
Marital status: single 77:9 79:1 0:9
Recruiting regional centers 0:9
Switzerland 47:7 51:2
France/Monaco 39:5 37:2
Italy 12:8 11:6
Highest educational degree obtained 0:4
Primary/grammar school 43:5 50:6
Apprenticeship/professional
school
24:7 27:1
High school/university 31:8 22:4
Diagnosis 0:2
Schizophrenia 77:9 84:9
Other psychotic disorders 22:1 15:1
PDI
Distress 21:0 (17:3) 25:3 (16:2) 0:05
Preoccupation 21:1 (15:8) 23:9 (14:9) 0:1
Conviction 27:0 (18:3) 29:8 (18:4) 0:1
BCIS
Self-reflectiveness 14:4 (5:0) 15:1 (4:6) 0:3
Self-certainty 8:4 (3:1) 8:9 (4:1) 0:2
Composite index 5:9 (6:3) 6:3 (6:5) 1:0
MADS: anything against the belief
Yes answers (%) 38:4 31:4 0:1
MADS: possibility of being mistaken
Yes answers (%) 57:0 52:3 0:7
MADS: response to hypothetical
contradiction (%)
Dismisses belief 25:6 12:8 0:2
Changes conviction 15:1 15:1
Accommodates 29:1 30:2
Ignores or rejects 30:2 41:9
MADS: ability to plan a behavioral
experiment (%)
Able to outline evidence and this
outcome logically possible
36:0 29:1 0:4
Able to outline evidence but this
outcome logically impossible
12:8 9:3
Unable to outline evidence which
would contradict his belief
51:2 61:6
MADS: awareness of illness (%)
Accept that has a mental illness or
nervous problem which includes
delusional belief
66:3 52:3 0:2
Accept that has a mental illness or
nervous problem but does not
include delusional belief
19:8 30:2
Not ill 14:0 17:4
BPRS
Affect 10:5 (4:2) 11:4 (4:3) 0:2
Negative symptoms 8:6 (3:9) 8:7 (3:9) 0:9
Positive symptoms 11:1 (4:4) 11:4 (3:3) 0:7
(Continued)
Baseline variables TAU MG p-Value
(n= 86) (n= 86)
Mean (SD)
or %
Mean (SD)
or %
Resistance 7:2 (2:9) 7:6 (2:6) 0:2
Activation 5:8 (2:5) 5:4 (2:6) 0:4
BPRS total score 42:8 (11:3) 44:5 (10:2) 0:3
GAF 43:6 (13:2) 43:0 (9:4) 0:8
SOFAS 43:7 (11:6) 43:6 (9:8) 1:0
Chlorpromazine equivalent (mg/day) 269:4 (222:1) 305:9 (297:9) 0:4
Summary statistics report means and SDs or percentages.
TAU, treatment as usual plus waiting list; MG, treatment as usual plus Michael’s game;
PDI, Peters delusions inventory; BCIS, Beck cognitive insight scale; MADS, Maudsley
assessment of delusions schedule; BPRS, brief psychiatry rating scale; GAF, global
assessment of functioning; SOFAS, social and occupational functioning assessment scale.
Quality Assurance
Group directors at each of the 16 collaborative centers (nurses,
psychologists, psychiatrists) were trained by the same method: a
standardized 1 h presentation and a 1 h training session for the
game. Training was directed by one of the game’s authors or by
one person authorized by the authors for his or her educational
qualities and experience in directing the game. Supervision was
also offered to game directors by the first author upon request.
Sessions were audiotaped (not available for all centers) to check
their fidelity to the intervention and were assessed with expected
therapist strategies extracted from the collaboration, interper-
sonal effectiveness, understanding, and guided discovery items of
the Haddock scale (35). Twenty-five randomly selected sessions
were assessed. The percentage of items rated as being compliant
with the desirable strategies ranged from 72 to 100%.
Statistical Analyses
At the patient level, baseline differences were checked between
the two study groups, as well as differences between completers
andnon-completers using t-tests, chi-square tests, or Fisher’s exact
tests where applicable.
The direct effect, or the short-term effect, of treatment on the
primary and on the secondary continuous outcomes was evalu-
ated through analyses of covariance (ANCOVAs) by considering
outcome values after the intervention at T2 and adjusting for the
respective baseline outcomes. The treatment group served as the
between-subject factor. These analyses were also controlled for
center to correct for a possible cluster effect and for medication.
Similarly, the long-term effect at T3 of the intervention was mea-
sured by ANCOVAS, using outcome values at T3 and adjusting
for the respective baseline outcomes. Finally, categorical MADS
variables were analyzed at T2 (short-term effect) and T3 (long-
term effect) through logistic regression analyses, with treatment
group as the between-subject factor, and were also adjusted for
baseline outcomes and controlled for center and medication. The
necessary application conditions of all these models were checked
and met.
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TABLE 3 | Evolution of primary and secondary outcome variables by treatment group.
Outcome variable T1 T2 T3 p-Valuea,b p-Valueb,c
TAU MG TAU MG TAU MG
PDI scores
Distress 21:0 (17:3) 25:3 (16:2) 19:7 (15:3) 20:2 (14:1) 16:9 (17:0) 15:1 (12:3) n.s.d 0.002
Preoccupation 21:1 (15:8) 23:9 (14:9) 19:6 (13:9) 18:5 (13:2) 16:9 (14:5) 14:3 (12:7) n.s. 0.001
Conviction 27:0 (18:3) 29:8 (18:4) 24:5 (17:2) 22:4 (15:7) 21:2 (16:3) 18:0 (14:3) 0.005 0.002
BCIS score
Self-reflectiveness 14:4 (5:0) 15:1 (4:6) 14:4 (5:0) 16:4 (5:0) 14:3 (4:3) 15:4 (4:6) n.s. n.s.
Self-certainty 8:4 (3:1) 8:9 (4:1) 8:2 (3:6) 7:9 (3:8) 8:3 (3:5) 7:7 (3:0) n.s. n.s.
Anything against the belief
Yes answers (%) 38:4 31:4 33:7 48:8 36:0 53:5 n.s. 0.001
Possibility of being mistaken n.s. n.s.
Yes answers (%) 57:0 52:3 54:7 61:6 51:2 69:8
Response to hypothetical contradiction (%) n.s. n.s.
Dismiss belief 25:6 12:8 41:9 25:6 53:5 36:0
Change conviction 15:1 15:1 9:3 31:4 8:1 23:3
Accommodate 29:1 30:2 19:8 30:2 19:8 31:4
Ignore or reject 30:2 41:9 29:1 12:8 18:6 9:3
Ability to plan a behavioral experiment (%) n.s. n.s.
Able to outline evidence and this outcome
logically possible
36:0 29:1 51:2 45:3 61:6 61:6
Able to outline evidence but this outcome
logically impossible
12:8 9:3 10:5 10:5 7:0 16:3
Unable to outline evidence which would
contradict his belief
51:2 61:6 38:4 44:2 31:4 22:1
Awareness of illness (%) n.s. n.s.
Accept that has a mental illness or nervous
problem which includes delusional belief
66:3 52:3 65:1 69:8 80:2 79:1
Accept that has a mental illness or nervous
problem but does not include delusional belief
19:8 30:2 14:0 18:6 10:5 12:8
Not ill 14:0 17:4 20:9 11:6 9:3 8:1
BPRS score
Affect 10:7 (4:2) 11:4 (4:3) 10:9 (3:9) 10:5 (4:2) 11:3 (4:1) 10:8 (4:0) n.s. n.s.
Negative symptoms 8:4 (3:8) 8:7 (3:9) 9:1 (3:6) 8:1 (3:8) 8:5 (3:0) 8:9 (3:9) n.s. n.s.
Positive symptoms 11:1 (4:3) 11:4 (3:3) 10:3 (4:1) 9:8 (4:0) 10:0 (3:8) 9:8 (3:8) n.s. n.s.
Resistance 7:1 (2:9) 7:6 (2:6) 6:3 (2:6) 6:4 (2:6) 6:6 (2:7) 6:3 (2:6) n.s. n.s.
Activation 5:5 (2:4) 5:4 (2:6) 5:4 (2:5) 5:3 (2:6) 5:5 (2:4) 5:5 (2:8) n.s. n.s.
GAF 43:5 (13:0) 43:0 (9:4) 47:5 (11:7) 48:0 (10:5) 47:0 (11:2) 48:7 (10:2) n.s. n.s.
SOFAS 43:8 (11:6) 43:7 (9:8) 47:1 (11:7) 48:4 (10:9) 46:4 (10:7) 49:0 (10:0) n.s. n.s.
ap-value resulting from analysis of short-term treatment effect.
bOnly significant results after Bonferroni’s correction are reported.
cp-value resulting from analysis of long-term treatment effect.
dn.s., not significant.
Interval variables are reported by their mean and SD [M (SD)] and categorical variables by their percentage (%).
TAU, treatment as usual plus waiting list; MG, treatment as usual plus Michael’s game; T1, baseline; T2, at 3months post-treatment; T3, at 6months follow-up; PDI, Peters
delusions inventory; BCIS, Beck cognitive insight scale; BPRS, brief psychiatry rating scale; GAF, global assessment of functioning; SOFAS, social and occupational functioning
assessment scale.
Bold font indicates significant p-value.
Adjusting for Multiple Testing
The trial was a priori powered for multiple time points at a
predefined 0.05 significance level, using PDI-21 conviction as the
primary outcome. Therefore, this level of significance was kept
when the primary outcome results were interpreted. However,
to minimize the chance of spurious results pertaining to the
secondary outcomes, we adjusted them for multiple testing by
Bonferroni’s correction (α 0.05/16= 0.0031). All the statistical
analyses were performedwith the Statistical Package for the Social
Sciences (SPSS version 18.0, IBM, Chicago, IL, USA).
Treatment of Missing Data
Analyses were done on an intention-to-treat basis, whereby all
randomized subjects were included. Categorical missing data
were imputed using logistic regressions. Quantitative missing
data were imputed by the expectation–maximization algorithm,
a statistical simulation technique that estimates the averages, the
matrix of variance and covariance, and the matrix of correlations.
After convergence, missing data are replaced by the estimation
obtained and the completed data are then analyzed by the usual
methods.
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Results
After screening and informed consent, 172 patients were included
and randomized for study participation (Figure 1).
Baseline Characteristics of Subjects
The mean age of the sample was 37.1 years (SD= 10.4). A high
school diploma or a university degree had been attained by 27.1%
of participants.Most participants had a diagnosis of schizophrenia
(81.4%), were single (78.5%), lived in a private residence (59.3%),
and had a disability pension (73.1%). Concurrent psychiatric
disorders at inclusion were common [i.e., substance use (15.6%);
anxiety disorders (27.2%)].
At baseline, the PDI-21 distress score was higher for the
MG group than for the TAU group at a trend level (p= 0.05).
There were no differences in the other main clinical measures
(Table 2).
Dropouts
At T2, dropout was associated with treatment allocation
(p= 0.01). Twenty-three of the TAU group patients and 10 of
the MG group patients discontinued the study. At T2, dropout
was also associated with younger age (p= 0.02). Furthermore,
dropouts were more common among patients who dismiss the
belief in response to hypothetical contradiction (p= 0.04) and
those more able to plan a behavioral experiment (p= 0.04).
There was no other statistically significant difference on the
other sociodemographic and clinical characteristics. Dropout at
T3 was associated with a younger age (p= 0.05) and recruiting
centers, where Switzerland had a statistically significant high
rate of dropouts during this period compared with the other
centers (p= 0.01). No other statistically significant difference was
observed.
FIGURE 2 | Evolution of PDI conviction raw scores by treatment group.
Outcomes
Table 3 presents patient outcomes at baseline, 3months, and
9months for the MG and TAU groups. Figure 2 depicts the
evolution of the PDI conviction raw scores.
Short-Term Treatment Effect (at T2) on the Primary
Outcome
After baseline values, medication, and the cluster effect of cen-
ter were controlled for, the results of the ANCOVAS showed a
short-term treatment effect for conviction (p= 0.005). After the
intervention, the estimated mean conviction was 29.0 for the
TAU group, whereas it was 24.3 for the MG group, which means
a short-term treatment effect of  4.7 points (95% CI [ 7.9 to
 1.4]).
Short-Term Treatment Effect (at T2) on the Secondary
Outcomes
No short-term effect was observed for the PDI-21 distress sub-
scale (p= 0.1), but an effect was observed for preoccupation
(p= 0.025), with an estimated mean of 22.3 for the TAU group
and 19.0 for theMG group, a treatment effect of 3.3 points (95%
CI [ 6.2 to  0.4]). However, after Bonferroni’s correction, this
effect was no longer significant.
No short-term treatment effect was observed for either Beck
self-reflectiveness (p= 0.08) or Beck self-certainty (p= 0.4). For
BPRS subscores (activation, affect, positive symptoms, and resis-
tance), no treatment effect was found (p= 0.6, p= 0.3, p= 0.4, and
p= 0.4, respectively). For BPRS negative symptoms, a treatment
effect was observed (p= 0.019) that was not sustained after Bon-
ferroni’s correction. GAF and SOFAS did not exhibit a treatment
effect (p= 0.1 and p= 0.9, respectively).With regard to theMADS
items, there was an effect for “anything against the belief ” inwhich
theMGgroupwasmore likely to answer “yes” than the TAUgroup
(OR= 3.16, 95% CI [1.30–7.70], p= 0.01). This effect, however,
was no longer significant after Bonferroni’s correction.
Long-Term Treatment Effect (at T3) on the Primary
Outcome
A sustained effect of the intervention was observed for conviction
(p= 0.002). At T3, the estimatedmean conviction was 24.6 for the
TAU group, whereas it was 18.8 for the MG group, a long-term
treatment effect of 5.7 points (95% CI [ 9.3 to 2.2]).
Long-Term Treatment Effect (at T3) on Secondary
Outcomes
A treatment effect was observed for distress, preoccupation, GAF,
and SOFAS (p= 0.002, p= 0.001, p= 0.03, and p= 0.02, respec-
tively). The mean scores for distress and preoccupation were
higher in the TAU group, whereas the mean scores for GAF and
SOFAS were higher in the MG group than in the TAU group.
However, after Bonferroni’s correction, the significance remained
only for distress and preoccupation, for which treatment effects
were estimated at  5.5 points (95% CI [ 9.0 to  2.0]) and  5.5
points (95% CI [ 8.6 to 2.2]), respectively.
Regarding MADS variables, a sustained treatment effect was
observed only for “anything against the belief ”: theMG group was
more likely to answer “yes” than the TAU group (OR= 4.95, 95%
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CI [1.85–13.27], p= 0.001). This effect remained significant after
Bonferroni’s correction.
Discussion
This study investigated the effects of a hypothetical reasoning
training module of short duration, called MG, in a sample of 172
outpatients with psychotic symptoms in 16 centers in France, Italy,
Monaco, and Switzerland. In accord with the main hypothesis,
the conviction score measured with the PDI-21 was improved
in the MG condition compared with the TAU condition at T2,
the post-intervention assessment. After Bonferroni’s correction,
no other effects on the secondary outcomes were observed at
post-intervention.
Six months later, the effect observed on the conviction score
of the PDI-21 was sustained. Furthermore, other effects were
observed, after Bonferroni’s correction, on the distress and pre-
occupation subscales of the PDI-21. In addition, these results in
the MG group were supplemented with an improvement in belief
flexibility, as measured with theMADS item “anything against the
belief.”
The results do not show specific effects on the BPRS scale.
The observed effects occurred on more detailed measures such
as the conviction subscale of the PDI-21 (the main outcome),
the distress and preoccupation subscales of the PDI-21, and one
of the MADS items. This pattern possibly indicates that MG
increases belief flexibility and changes the relation of the partici-
pants to their symptoms to some extent. As suggested elsewhere
(19), the effect of CBT on psychotic disorders is probably of
more interest for outcomes such as distress, preoccupation, and
conviction related to beliefs than it is for psychotic symptoms
as measured by the BPRS. Indeed, through specific training on
hypothetical reasoning, MG seems to promote other viewpoints
about what happens (as suggested by the observed changes on
the PDI-21 and on the MADS), which is considered particu-
larly helpful to patients dealing with stressful positive symp-
toms (9).
In the present study, as reported in a number of other studies on
psychotherapy (36–43), post-intervention effects were sustained
at follow-up on the primary outcome. The further improvements
observed at follow-up on some outcomes possibly suggests that
the effect of the intervention fosters additional changes. One may
hypothesize that the first improvements on conviction and the
patient’s possible appropriation of the model of reasoning with
hypotheses may allow additional experiences in daily life, and
then improvements for at least some patients, as suggested by a
previous case report (44). Future studies are needed, however,
in order to assess the process that may be involved in such
supposed effects.
One can also hypothesize that the game could be used as
a warm-up program before applying it to an individualized
CBT intervention for psychosis. The fidelity checks indicate
good fidelity to the intervention in the assessed centers. These
results show that an easy-to-use program such as MG may facili-
tate the dissemination of CBT (specifically hypothetical reason-
ing training) for psychosis in natural settings. The game may
also familiarize health care professionals with the use of CBT
techniques for psychosis. This of particularly high interest in
consideration of the scarcity of psychotherapeutic treatments
offered in clinical settings for people with psychotic disorders (16,
17, 45).
Dropout was relatively low. The game format may increase
therapeutic alliance, a possible mediating factor of treatment out-
comes in patients with psychosis (46). This aspect was not studied
in the present paper, however, and may merit further studies.
Dropout at T2 was associated with variables such as a younger
age and a higher percentage of participants who dismissed the
belief in response to a hypothetical contradiction. These patients
possibly perceived less utility in the game than other patients did.
The dropout rate associated with younger participants is in accor-
dance with other observations (47) and suggests that the module
could be improved to better engage them in the intervention or
could be completed with other recovery-oriented interventions
and psycho-education (20, 48).
In the absence of an active control group in our study, we
cannot exclude the possibility that the observed effects were due
to non-specific psychotherapeutic effects such as non-specific
attention and interactions with the game leaders and other
patients (45, 49). In addition, the absence of audiotaped sessions
in some centers to control for fidelity to the intervention by
group leaders may have missed poor fidelity in some centers.
The lack of precise comparison of the TAU components in the
16 centers may have influenced the results. However, the anal-
yses were controlled for center to correct for a possible clus-
ter effect.
The multicentre design of the study may increase the pos-
sible generalization of the results. Furthermore, as reported in
other studies (50), the limited number of exclusion criteria could
contribute to the external validity of the study. We cannot fully
rule out the influence of factors such as comorbid disorders (i.e.,
substance use disorders) or variations in cognitive deficits on the
treatment outcomes.
Conclusion
The results of this study indicate that the use ofMG, a hypothetical
reasoning trainingmodule, may improve belief flexibility and self-
assessment of delusion in patients with psychotic disorders in
comparison with not using it. MG appears to be a short and easy-
to-use intervention to disseminate CBT for psychosis in routine
clinical settings. Further studies with active control group are still
needed to improve the understanding of the possible effect of the
game.
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